RRMS patients started on high-efficacy treatments may have less reduction in work capacity than those on moderate-efficacy ...

Cybin (NYSE American: CYBN) (NEO: CYBN) announced that CEO Doug Drysdale will participate in a fireside chat at the virtual Alliance Global Partners ...